Showing results (11-20 of 152) with videos related to
Sort By:
Pageof 16
Hepatology (Baltimore, Md.)|February 16, 2012
Pegylated interferon-α induced hypoferremia is associated with the immediate response to treatment in hepatitis CJohn D Ryan, Sandro Altamura, Emma Devitt, et al.European Journal of Gastroenterology & Hepatology|December 18, 2010
Early proteomic analysis may allow noninvasive identification of hepatitis C response to treatment with pegylated interferon α-2b and ribavirinEmma J Devitt, Karen A Power, Matthew W Lawless, et al.Cytokine|October 15, 2013
Stop feeding cancer: pro-inflammatory role of visceral adiposity in liver cancerJun Zhao, Matthew W LawlessHuman Immunology|May 18, 2010
Variant in CD209 promoter is associated with severity of liver disease in chronic hepatitis C virus infectionElizabeth J Ryan, Megan Dring, Cliona M Ryan, et al.Arthritis Research & Therapy|March 21, 2013
Perspectives on epigenetic-based immune intervention for rheumatic diseasesSteven G GrayCNS Neuroscience & Therapeutics|July 21, 2010
Targeting histone deacetylases for the treatment of Huntington's diseaseSteven G GrayBMC Pulmonary Medicine|May 6, 2021
Emerging avenues in immunotherapy for the management of malignant pleural mesotheliomaSteven G GrayClinical Epigenetics|June 19, 2012
Targeting Huntington's disease through histone deacetylasesSteven G GrayPageof 16